Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-22 Sale |
2021-12-27 12:20 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | De Groot Eleanor EVP, Operations |
20,132 | $1.27 | $25,568 | 237,106 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-17 4:53 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Boyle Kevin S. Sr. Chief Executive Officer |
10,000 | $1.4 | $14,000 | 885,000 (Direct) |
View |
| 2021-09-29 Purchase |
2021-10-04 6:11 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Vieser Jaime Director |
100,000 | $1.91 | $191,000 | 1,030,321 (Indirect Direct) |
View |
| 2021-09-02 Purchase |
2021-09-03 5:25 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Hagen Heidi Director |
23,770 | $1.76 | $41,835 | 145,889 (Direct) |
View |
| 2021-09-01 Purchase |
2021-09-03 5:23 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Weis Holger Director |
50,000 | $1.83 | $91,500 | 141,607 (Indirect Direct) |
View |
| 2021-09-02 Purchase |
2021-09-03 5:22 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Postma Robert W Director |
75,000 | $1.73 | $129,750 | 5,455,444 (Indirect Direct) |
View |
| 2021-09-01 Purchase |
2021-09-03 5:21 pm |
ZIOPHARM ONCOLOGY INC | ZIOP | Huang James Director |
100,000 | $1.71 | $171,000 | 108,333 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-15 Option Award |
2022-09-19 4:30 pm |
N/A 2032-09-14 |
Alaunos Therapeutics Inc. | TCRT | Deniger Drew VP, Research and Development |
305,000 | $0 | 305,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 4:30 pm |
N/A 2032-09-14 |
Alaunos Therapeutics Inc. | TCRT | Srivastava Abhishek K See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 4:30 pm |
N/A 2032-09-14 |
Alaunos Therapeutics Inc. | TCRT | Wong Michael VP, Finance |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 4:30 pm |
N/A 2032-09-14 |
Alaunos Therapeutics Inc. | TCRT | Lackey Melinda Senior Vice President, Legal |
185,000 | $0 | 185,000 (Direct) |
View |
| 2022-08-30 Tax Withholding |
2022-09-01 4:30 pm |
N/A N/A |
Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer |
18,750 | $2.41 | 866,250 (Direct) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:00 pm |
N/A 2032-08-02 |
Alaunos Therapeutics Inc. | TCRT | Srivastava Abhishek K See Remarks |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2022-08-15 5:46 pm |
N/A N/A |
Alaunos Therapeutics Inc. | TCRT | Srivastava Abhishek K See Remarks |
0 | $0 | 1,200 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Thistle Mary Director |
140,000 | $0 | 145,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Huang James Director |
180,000 | $0 | 288,333 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Postma Robert W Director |
140,000 | $0 | 5,595,444 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Thistle Mary Director |
140,000 | $0 | 145,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Huang James Director |
180,000 | $0 | 288,333 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Postma Robert W Director |
140,000 | $0 | 5,595,444 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Vieser Jaime Director |
140,000 | $0 | 1,170,321 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Bowden Christopher Director |
140,000 | $0 | 144,167 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:30 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Weis Holger Director |
140,000 | $0 | 281,607 (Direct) |
View |
Ownership |
2022-04-08 4:30 pm |
N/A N/A |
Alaunos Therapeutics Inc. | TCRT | Deniger Drew VP, Research & Development |
0 | $0 | 455,000 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:30 pm |
N/A 2032-03-29 |
Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer |
2,000,000 | $0 | 2,000,000 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:30 pm |
N/A 2032-03-29 |
Alaunos Therapeutics Inc. | TCRT | De Groot Eleanor EVP, Operations |
350,000 | $0 | 350,000 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-13 06:06 am |
N/A 2031-12-09 |
ZIOPHARM ONCOLOGY INC | ZIOP | Lackey Melinda Senior Vice President, Legal |
370,000 | $0 | 370,000 (Direct) |
View |
Ownership |
2021-11-29 6:40 pm |
N/A 2031-11-02 |
ZIOPHARM ONCOLOGY INC | ZIOP | Wong Michael Vice President of Finance |
0 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-31 4:42 pm |
N/A 2031-08-29 |
ZIOPHARM ONCOLOGY INC | ZIOP | Boyle Kevin S. Sr. Chief Executive Officer |
3,500,000 | $0 | 3,500,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 4:55 pm |
N/A N/A |
ZIOPHARM ONCOLOGY INC | ZIOP | Baffa Raffaele Chief Medical Officer |
80,645 | $0 | 280,645 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:27 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Weis Holger Director |
185,417 | $0 | 272,857 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:26 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Vieser Jaime Director |
185,417 | $0 | 1,111,571 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:25 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Thistle Mary Director |
192,500 | $0 | 192,500 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:24 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Postma Robert W Director |
171,250 | $0 | 5,549,194 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:22 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Huang James Director |
70,833 | $0 | 70,833 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:21 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | BUCHI J KEVIN Director |
35,417 | $0 | 35,417 (Direct) |
View |
| 2021-03-04 Option Award |
2021-05-06 7:20 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Bowden Christopher Director |
35,417 | $0 | 35,417 (Direct) |
View |
Ownership |
2021-03-31 4:24 pm |
N/A N/A |
ZIOPHARM ONCOLOGY INC | ZIOP | Baffa Raffaele Chief Medical Officer |
0 | $0 | 700,000 (Direct) |
View |